Skip to main content
Equibles

Capital International Investors

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1562230 Los Angeles, CA
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$121,757,989
+$24,822,414 QoQ
Shares Held
2,921,958
-5.7% QoQ
Ownership
6.09%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 159 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. RAPP ranks #9 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,695,144 $2,332,218,879
2 RPRX
Royalty Pharma plc
 35,273,770 $1,977,800,283
3 ONC
BeOne Medicines Ltd.
 4,210,221 $1,199,786,678
4 INSM
INSMED Inc
 8,238,124 $878,348,780
5 ASND
Ascendis Pharma A/S
 1,988,614 $530,403,126
6 XENE
Xenon Pharmaceuticals Inc.
 2,361,639 $142,548,530
7 DFTX
Definium Therapeutics, Inc.
 2,963,410 $139,398,806
8 COAG
Hemab Therapeutics Holdings, Inc.
 3,603,876 $132,370,365

All Filings in RAPP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $121,757,989 2,921,958
2026-03-31 $96,935,575 3,097,973
2025-12-31 $103,232,729 3,402,529
2025-09-30 $101,055,111 3,402,529
2025-06-30 $29,590,754 2,602,529
2025-03-31 $26,103,365 2,602,529
2024-12-31 $46,168,864 2,602,529
2024-09-30 $53,299,793 2,602,529
2024-06-30 $60,534,871 2,602,531